Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Seres Therapeutics, Inc. | 8,562 | reported | 18 May 2026 | tx 5+56,430−239 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 180 | — | |
| 18 May 2026 | SALE | Seres Therapeutics, Inc. | 59 | 7.53 USD | |
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 89 | 0.00 USD | deriv |
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 91 | 0.00 USD | deriv |
| 04 Mar 2026 | GRANT_AWARD | Seres Therapeutics, Inc. | 56,250 | 0.00 USD | deriv |